Speeches & presentations
Search through our archive of speeches and presentations from conferences and events.
Filter by
-
34th Annual JP Morgan Healthcare Conference, San Francisco USA
Andrew Witty, CEO, gave a presentation at the 34th Annual JP Morgan Healthcare Conference in San Francisco, providing an overview of progress the company has made during 2015.
-
David Redfern
David Redfern, Chief Strategy Officer, discusses the two transactions with Bristol-Myers Squibb to acquire their late-stage HIV pipeline assets and also their pre-clinical and discovery stage research assets.
-
R&D event
On Tuesday 3 November, we hosted an event focusing on our R&D pipeline. This provided a unique insight into the innovative medicines and vaccines that GSK is developing for the future.
-
Investor event
The Investor event outlined the Group’s strategy for 2015 and beyond including presentations from the heads of our Vaccines, Pharmaceuticals and Consumer businesses together with Sir Andrew Witty, Chief Executive Officer and Simon Dingemans, Chief Financial Officer.
-
33rd Annual JP Morgan Healthcare Conference
David Redfern, Chief Strategy Officer, gave a presentation at the 33th Annual JP Morgan Healthcare Conference in San Francisco.
-
Bank of America Merrill Lynch Global Healthcare Conference, London UK
Simon Dingemans, Chief Financial Officer, gave a presentation at the Bank of America Merrill Lynch Global Healthcare conference in London on 19th September 2014. Simon provided an overview of the recent results and the shape of the company going forward.
-
Investor Event at ERS 2014, Munich
Darrell Baker, Senior Vice President, Head of Global Respiratory Franchise hosted an investor event comprising a presentation and Q&A session based on data presented at ERS.
-
Citi Global Healthcare Conference, New York USA
Andrew Witty, CEO, presented at the Citi Global Healthcare Conference on February 24, 2014 in New York. Andrew opened with a few minutes of brief remarks followed by a 'fireside chat' question and answer session.
-
32nd Annual JP Morgan Healthcare Conference, San Francisco USA
Simon Dingemans, Chief Financial Officer, gave a presentation at the 32nd Annual JP Morgan Healthcare Conference in San Francisco. Simon provided an overview of the progress being made in implementing the company’s strategy.
-
Leerink Swann PolarXpress, Philadelphia
Dr Paolo Paoletti, President of GSK Oncology, hosted an investor event organized by Leerink Swann at the GSK offices in Philadelphia.
-
North Carolina CEO Forum
Deirdre Connelly, President, North America Pharmaceuticals, spoke at the North Carolina CEO Forum about the importance of curiosity, vision, flexibility, and risk-taking to create a high-performing, innovative, and sustainable business.
-
Goldman Sachs 34th Annual Global Healthcare Conference, California USA
David Redfern, Chief Strategy Officer, gave a fireside chat on GSK’s business strategy and addressed questions in front of a large group of US investors at the Goldman Sachs Conference in California on Wednesday 12 June 2013.
Webcast -
Investor Event at ATS 2013, Philadelphia
Darrell Baker, Senior Vice President, Head of Global Respiratory Franchise hosted an investor event comprising a short presentation and Q&A session based on data presented at ATS.
-
Leerink Swann Healthcare Conference
Simon Dingemans, Chief Financial Officer, addressed questions in front of a large group of US investors at the Leerink Swann Global Healthcare Conference on Wednesday, February 13 in New York. Simon provided an overview of GSK’s 2012 full year results and outlook for the future.
Webcast -
Late-stage pipeline review - Patrick Vallance
Patrick Vallance, President, Pharmaceutical R&D gave a presentation at the 31st Annual JP Morgan Healthcare Conference in San Francisco. Patrick provided a review of the progress being made on the late stage pipeline.
-
Late-stage pipeline review - Sir Andrew Witty, Dr Moncef Slaoui, and Dr Patrick Vallance
Sir Andrew Witty (CEO), Dr Moncef Slaoui (Chairman of R&D) and Dr Patrick Vallance (President of Pharmaceutical R&D) together with senior R&D leaders hosted a seminar focusing on GSK’s late stage pipeline. The event brought together the progress made in 2012, as Phase III programmes for a significant number of potential new drugs have concluded. It also provided an overview of our progress on our returns driven strategy in R&D and the sustainability of our pipeline.
-
Annual Pharmaceutical Regulatory and Compliance Congress
Deidre Connelly, President North America Pharmaceuticals, spoke at the 13th Annual Pharmaceutical Regulatory and Compliance Congress about how we conduct our business.
-
Investor Meeting at ESMO, Vienna
Dr Paolo Paoletti, President of GSK Oncology, hosted an investor event in conjunction with data presented at the European Society for Medical Oncology.
-
Investor Meeting at IAC, Washington
ViiV Healthcare Chairman David Redfern, CEO Dominique Limet and Chief Scientific and Medical Officer, John Pottage, hosted an investor event at the International AIDS Conference (IAC).
-
Investor Meeting at ADA, Philadelphia
Dr Carlo Russo, Senior Vice President and Head of Albiglutide Development hosted an investor event in conjunction with data presented at the American Diabetes Association meeting.
